MA
NVO

MSA Advisors’s Novo Nordisk NVO Stock Holding History

MSA Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129K Hold
3,500
– – 0.04% 47
2025
Q4 		$178K Hold
3,500
– – 0.04% 27
2025
Q3 		$194K Hold
3,500
– – 0.05% 27
2025
Q2 		$242K Hold
3,500
– – 0.06% 24
2025
Q1 		$243K Hold
3,500
– – 0.06% 26
2024
Q4 		$301K Hold
3,500
– – 0.08% 23
2024
Q3 		$417K Hold
3,500
– – 0.11% 21
2024
Q2 		$500K Hold
3,500
– – 0.14% 20
2024
Q1 		$452K Hold
3,500
– – 0.14% 20
2023
Q4 		$362K Buy
+3,500
New +$346K 0.13% 19

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

MSA Advisors's NVO Position: Q1 2026 in Review

MSA Advisors held its Novo Nordisk (NVO) position steady in Q1 2026 at 3,500 shares worth $129K. The position accounts for 0.04% of the portfolio, ranked #47.

MSA Advisors first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $500K in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • MSA Advisors held 3,500 shares of Novo Nordisk worth $129K as of Q1 2026.
  • MSA Advisors left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up 0.04% of MSA Advisors's portfolio in Q1 2026, its #47 holding.
  • MSA Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • MSA Advisors's Novo Nordisk position peaked at $500K in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on MSA Advisors's 13F filing for Q1 2026, filed 18 May 2026.